COMMUNIQUÉS West-GlobeNewswire

Imviva Biotech Presents Studies on CTD402 Allogeneic CAR-T Therapy at EHA2026 Congress
11/06/2026
Pooled Phase 1/2 data show 80% complete remission rate in pediatric R/R T-ALL/LBL patients Global TENACITY-01 study reports 86% overall response rate in adults with R/R T-ALL/LBL BOSTON, June 11, 2026 (GLOBE NEWSWIRE [...]
Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition
11/06/2026
BOSTON, June 11, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases [...]
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
11/06/2026
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply [...]
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
11/06/2026
In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18) ORR, 89% (16/18) CRc and 78% (14/18) CR, and continued to demonstrate a favorable [...]
Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program
11/06/2026
Management Believes the Company is Entering a Transformative Stage with a Novel, First-In-Class Cancer Therapy for Treatment & Prevention of Metastatic Cancer from Solid Tumors MELBOURNE, Australia, June 11, 2026 ( [...]
KFSH Advances Practical AI Applications Driving Transformation Across Specialized Healthcare
11/06/2026
RIYADH, Saudi Arabia, June 11, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will highlight its practical applications of artificial intelligence during its participation at HLTH [...]
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
11/06/2026
The clearance combines OraSure’s Colli-Pee™•Dx Urine Collection Kit for at-home sample collection with Roche’s cobas® molecular lab testing equipment BETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure [...]
Sharecare wins 14 Digital Health Awards in Spring 2026 competition
11/06/2026
Company earns five Golds for its interactive patient education tools, health literacy content, and evidence-based behavioral health apps ATLANTA, June 11, 2026 (GLOBE NEWSWIRE) -- Sharecare, the digital health [...]
Parexel to Highlight Expertise Across Eight Thought Leadership Sessions at 2026 DIA Global Annual Meeting
11/06/2026
Presentations, panels and moderated discussions across the four-day conference will span proven AI applications across the clinical trial lifecycle, real world evidence, risk-based quality management and patient- [...]
VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor
11/06/2026
Structured Market Entry Includes Initial Purchase Order and Pathway to Five-Year Commercial Partnership VANCOUVER, BC, June 11, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a [...]
FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM
11/06/2026
Flyte to expand private aviation demand, increase aircraft utilization, and accelerate revenue growth Flyte Gains Access to Fast-Growing Private Aviation Membership Network While Unlocking New Revenue Opportunities [...]
Announcing the 2026 Hall of Fame Philadelphia Titan 100 Honorees
11/06/2026
BERWYN, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- Titan CEO and headline sponsor Cherry Bekaert are pleased to announce Dea Belazi, CEO and co-founder, AscellaHealth , a global partner delivering customizable solutions for [...]
Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026
11/06/2026
BERKELEY HEIGHTS, N.J., June 11, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix" or the "Company"), a fully-integrated, commercial-stage biotechnology company, today announced that [...]
Pharvaris Announces Annual General Meeting of Shareholders
11/06/2026
ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living [...]
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population
11/06/2026
At the 100 µg Recommended Phase 2 Dose (RP2D), Cemsidomide Demonstrated a 53% Overall Response Rate, Including Complete Responses and Minimal Residual Disease (MRD) Negative Status Cemsidomide Was Well Tolerated With [...]
BrewDog Rolls Back Pint Prices to £2 Across Scotland for 72-Hour Bank Holiday Weekend, Celebrating the National Team’s Return
11/06/2026
ELLON, Scotland, June 11, 2026 (GLOBE NEWSWIRE) -- BrewDog , one of the U.K.’s leading and most recognizable craft beer brands, part of Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), is rolling pint prices back to [...]
Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia
11/06/2026
CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare hematologic malignancies, today announced that the first patient has been dosed in [...]
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
11/06/2026
NEW YORK and TORONTO, June 11, 2026 (GLOBE NEWSWIRE) -- Helus Pharma TM (Nasdaq: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists [...]
Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
11/06/2026
New U.S. patents extend protection for cellular immunotherapy applications, immune cell targeting constructs and bizaxofusp combination therapy with anti-VEGF agents for CNS tumors; global portfolio now exceeds 100 [...]

Pages